Close Menu

NEW YORK – The US Food and Drug Administration on Monday released guidance outlining how developers of companion diagnostics for personalizing cancer therapies can broaden the indication for a test so that it references a group of similar drugs instead of a specific treatment. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.